Search Within

Michel W J Sadelain

Formats
  1. Meeting Abstract (289)
  2. Journal Article (279)
  3. Review (5)
  4. Editorial (4)
  5. Conference Paper (3)
  6. Research Letter (3)
  7. Book Section (2)
Groups
  1. Center for Hematologic Malignancies (585)
  2. Department of Medicine (585)
  3. GSK Faculty (585)
  4. Hematologic Malignancies Research (585)
  5. Hematologic Malignancies, Division of (585)
  6. Molecular Pharmacology and Chemistry Program Faculty (585)

More Groups

People
  1. Isabelle Riviere (200)
  2. Renier Brentjens (116)
  3. Xiuyan Wang (91)
  4. Jae Park (83)
  5. Jorge Mansilla-Soto (43)
  6. Kevin Curran (36)

More People

Years
  1. 2025 (6)
  2. 2024 (10)
  3. 2023 (21)
  4. 2022 (18)
  5. 2021 (23)
  6. 2020 (16)

More Years

Publications
  1. Blood (133)
  2. Molecular Therapy (56)
  3. Cancer Research (24)
  4. Journal of Clinical Oncology (18)
  5. Nature Biotechnology (13)
  6. Blood Cells, Molecules, and Diseases (12)

More Publications

Publishers
  1. American Society of Hematology (134)
  2. Nature Publishing Group (126)
  3. Elsevier Inc. (49)
  4. American Association for Cancer Research (46)
  5. American Society of Clinical Oncology (19)
  6. Cell Press (16)

More Publishers

Results (585)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safe and effective re-induction of complete remissions in adults with relapsed B-ALL using 19-28z CAR CD19-targeted T cell therapy
    Meeting Abstract

    Davila, M. L.; Riviere, I.; Wang, X.; Bartido, S.; Stefanski, J.; He, Q.; Borquez-Ojeda, O.; Taylor, C.; Wasielewska, T.; Qu, J.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • First US phase I clinical trial of globin gene transfer for the treatment of beta-thalassemia major
    Meeting Abstract

    Boulad, F.; Riviere, I.; Wang, X.; Bartido, S.; Prockop, S. E.; Barone, R.; Moi, P.; Maggio, A.; Sadelain, M.
    Blood (2013)

    Fulltext@MSK | Save
  • T-cell imaging to noninvasively monitor adoptive T-cell therapy for thoracic malignancies
    Meeting Abstract

    Villena-Vargas, J.; Rodriguez, L. A.; Moroz, M.; Cherkassky, L.; Rusch, V. W.; Sadelain, M.; Ponomarev, V.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Critical role of CD28 costimulation in tumor-targeted T-cell therapy clinical trial for pleural malignancies
    Meeting Abstract

    Villena-Vargas, J.; Cherkassky, L.; Colovos, C.; Servais, E.; Rodriguez, L. A.; Rusch, V. W.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • CD8 T-cell infiltration and tumor IL-7R expression are independent prognostic factors in epithelioid malignant pleural mesothelioma
    Meeting Abstract

    Ujiie, H.; Buitrago, D.; Nitadori, J.; Kadota, K.; Krug, L. M.; Travis, W. D.; Rusch, V. W.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • The tumor immune microenvironment in octogenarians with stage I non-small cell lung cancer: Implications for immunotherapy
    Meeting Abstract

    Lee, M. C.; Kadota, K.; Ujiie, H.; Rizk, N. P.; Travis, W. D.; Rusch, V. W.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Prognostic impact of tumor-infiltrating immune cells in lung squamous cell carcinoma
    Meeting Abstract

    Bograd, A.; Kadota, K.; Nitadori, J.; Cherkassky, L.; Rusch, V. W.; Travis, W. D.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Transduction susceptibility and engraftment potential of genetically-modified human thalassemic CD34+cells collected by different mobilization approaches
    Meeting Abstract

    Karponi, G.; Psatha, N.; Zogas, N.; Zervou, F.; Tsatalas, K.; Sadelain, M.; Riviere, I.; Anagnostopoulos, A.; Stamatoyannopoulos, G.; Yannaki, E.
    Human Gene Therapy (2013)

    Fulltext@MSK | Save
  • PD-1- and CTLA-4-based inhibitory chimeric antigen receptors (iCARs) divert off-target immunotherapy responses
    Journal Article

    Fedorov, V. D.; Themeli, M.; Sadelain, M.
    Science Translational Medicine (2013)

    Fulltext@MSK | Save
  • Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer
    Journal Article

    Baiz, D.; Hassan, S.; Choi, Y. A.; Flores, A.; Karpova, Y.; Yancey, D.; Pullikuth, A.; Sui, G.; Sadelain, M.; Debinski, W.; more...
    NeoPlasia (2013)

    Fulltext@MSK | Save